Wed, Jul. 20, 8:48 AM
- Unilever (UL, UN) confirms it acquired Dollar Shave Club. The company didn't disclose the transaction price, but earlier reports pegged it at $1B which would make the deal the third largest buyout in the e-commerce space ever after Zulilly and Wayfair. The transaction is also an exclamation point on the disruption that Dollar Shave Club achieved in a consumer products category once considered nearly impenetrable.
- The innovative shaving club sends razors directly to members for as little as $1 per month. Dollar Shave Club is on track to top $200M in turnover this year and has 3.2M members.
- Earlier this week, news broke that Procter & Gamble (NYSE:PG) is increasing its testing of online subscriptions. It's a trend to watch for Colgate-Palmolive (NYSE:CL), Kimberly-Clark (NYSE:KMB), and Edgewell Personal Care (NYSE:EPC).
- Previously: Fortune: Unilever buys Dollar Shave Club for $1B (July 20)
Jan. 7, 2015, 10:59 AM
- Most investment firms weighing in think PepsiCo (PEP +2.3%) is too big of a target for 3G to land as they dissect the WSJ report on interest in the multinational.
- Campbell Soup (CPB +4.3%) is trading like it's viable 3G target, while Kellogg K, and Kraft Food Group (KRFT +2.1%) have also been bandied around by retail analysts as possibilities.
- Outside of the food sector, Bloomberg's Tara Lachappelle notes Colgate-Palmolive (CL +0.2%) makes sense for 3G.
Oct. 28, 2014, 1:36 PM
Sep. 24, 2014, 9:38 AM
- Colgate-Palmolive (NYSE:CL) is an attractive acquisition target with its core products seeing increasing demand in developing nations, reasons Bloomberg.
- Despite the company's large size, its broad distribution network could push a buyer to stretch the wallet a bit.
- A large balance sheet and a global reach would be needed to contemplate a Colgate-Palmolive takeover. Unilever (NYSE:UL) and Johnson & Johnson (NYSE:JNJ) might fit the bill, note analysts.
Jul. 15, 2011, 4:50 PMChris Stuart questions whether Clorox (CLX +8.9%) is really worth $100/share, as Carl Icahn claims it would be to a potential acquirer such PG, UL, CL, or KMB. At $100, Clorox, which recently forecast FY2012 growth of just 1-3%, would trade at nearly 25x its estimated FY2012 EPS. | Jul. 15, 2011, 4:50 PM | 1 Comment
Jul. 15, 2011, 6:25 AM
Icahn notes Clorox (CLX) "will not come close" to meeting sales growth forecasts of 3-5%/year. His offer is an attempt to prod CLX to pursue a deal with a "strategic buyer" (PG, UN, CL, KMB, Reckitt Benckiser, Henkel) - who Icahn believes will pay a higher price. "Quite simply, there are few strategic opportunities like Clorox."| Jul. 15, 2011, 6:25 AM | 1 Comment